Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-10-30 CAGNONI PABLO J Director Sale −7,500 $52.00 $390K 0
2019-10-30 CAGNONI PABLO J Director Option exercise · Stock Option (Right to Buy) −7,500 78,833
2019-10-30 Bolzon Bradley J PhD Director Sale −21,000 $51.89 $1.1M 13,745
2017-11-13 TOMSICEK MICHAEL JOHN Chief Financial Officer Option exercise · Stock Option (Right to Buy) −12,000 168,000
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +2,942,560 2,942,560
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion +211,567 3,154,127
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Purchase +66,500 $14.00 $931K 3,220,627
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series A-3 Preferred Shares −2,942,560 0
2016-10-24 GLAXOSMITHKLINE PLC 10% owner Conversion · Series B Preferred Shares −211,567 0
2016-10-18 GLAXOSMITHKLINE PLC 10% owner Grant or award · Stock Option +30,000 30,000

Page 46 of 46 · 910 trades